Ofloxacin (Standard)
Based on 1 Customer Validation
Ofloxacin (Standard) is the analytical standard of Ofloxacin. This product is intended for research and analytical applications. Ofloxacin (Hoe-280) is a fluoroquinolone whose primary mechanism of action is inhibition of bacterial DNA gyrase. Ofloxacin shows inhibitory activity against vaccinia virus (VV).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.41%
- CAS No.: 82419-36-1
- Formule: C₁₈H₂₀FN₃O₄
- Masse moléculaire:361.37
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-B0308
SparfloxacinBacterial Inhibitor -
HY-B0125
OfloxacinBacterial Inhibitor -
HY-B0356
CiprofloxacinTopoisomerase IV Inhibitor -
HY-B0272
RifampicinAntivirus Agent -
HY-B0356R
Ciprofloxacin (Standard)Reference Standard -
HY-16562
IrinotecanTopoisomerase I Inhibitor -
HY-B0330
LevofloxacinDNA Gyrase/Topoisomerase Inhibitor -
HY-B0183
Ellagic acidSHP2 Inhibitor -
HY-13725
PirarubicinAutophagy Inducer -
HY-16560
CamptothecinTopo I inhibitor -
HY-13768
TopotecanTopo I Inhibitor -
HY-13768A
Topotecan hydrochlorideTopoisomerase I Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 82419-36-1
-
Appearance Solid
-
Masse moléculaire 361.37
-
Formule C₁₈H₂₀FN₃O₄
-
Color White to off-white
-
SMILES
O=C(C(C1=O)=CN2C(C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O
-
Synonyms
Hoe-280 (Standard)
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
SDS (558 KB)
- English - EN (558 KB)
- Français - FR (558 KB)
- Deutsch - DE (558 KB)
- Norwegian - NO (558 KB)
- Español - ES (558 KB)
- Swedish - SV (558 KB)
- Italian - IT (558 KB)
- Korean - KR (558 KB)
- Portuguese - PT (558 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Todd PA, et al. Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use. Drugs. 1991 Nov;42(5):825-76. [Content Brief]
[2]. Smith JT, et al. Ofloxacin, a bactericidal antibacterial. Chemotherapy. 1991;37 Suppl 1:2-13. [Content Brief]
[3]. Olcay E, et al. Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats. J Toxicol Sci. 2011 Jun;36(3):339-45. [Content Brief]
[4]. S Ikeda , et al. Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative. Antiviral Res. 1987 Oct;8(3):103-13. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ofloxacin (Standard) Related Classifications
HY-B0125R Related Classifications
Powered by Bioz